GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy
Modern Pathology · 2023
DOI: 10.1016/j.modpat.2023.100102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Takashi Kokumai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Surgery, Tohoku University Graduat…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Pancreatic Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Relevant protein expression of GATA6, CK5, vimentin, and mucins using immunohistochemistry was assessed for predicting the prognosis of and chemotherapy efficacy in patients with pancreatic cancers (PCs). The protein expression was examined in 159 PCs resected after neoadjuvant chemotherapy (NAC-PCs) and compared with that of 120 matched biopsy specimens taken before NAC. KRAS mutations were assessed by digital PCR. NAC-PCs were classified by GATA6 expression initially and CK5 expression subsequently into 4 types: classical-type (n = 22) with GATA6-high (≥50%)/CK5-low (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Investigative Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan; Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
- Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
- Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan; Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
- Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Zitieren
APA
Kokumai, T., Omori, Y., Ishida, M., Ohtsuka, H., Mizuma, M., Nakagawa, K., Maeda, C., Ono, Y., Mizukami, Y., Miura, S., Kume, K., Masamune, A., Morikawa, T., Unno, M., & Furukawa, T. (2023). GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100102
Vancouver
Kokumai T, Omori Y, Ishida M, Ohtsuka H, Mizuma M, Nakagawa K, et al. GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100102
BibTeX
@article{Kokumai2023,
author = {Kokumai, Takashi and Omori, Yuko and Ishida, Masaharu and Ohtsuka, Hideo and Mizuma, Masamichi and Nakagawa, Kei and Maeda, Chiho and Ono, Yusuke and Mizukami, Yusuke and Miura, Shin and Kume, Kiyoshi and Masamune, Atsushi and Morikawa, Takanori and Unno, Michiaki and Furukawa, Toru},
title = {GATA6 and CK5 Stratify the Survival of Patients With Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy},
journal = {Modern Pathology},
year = {2023},
doi = {10.1016/j.modpat.2023.100102}
}
EUVIMED